Literature DB >> 26812789

Effect of molecular chaperones on aberrant protein oligomers in vitro: super-versus sub-stoichiometric chaperone concentrations.

Sara Cappelli, Amanda Penco, Benedetta Mannini, Roberta Cascella, Mark R Wilson, Heath Ecroyd, Xinyi Li, Joel N Buxbaum, Christopher M Dobson, Cristina Cecchi, Annalisa Relini, Fabrizio Chiti.   

Abstract

Living systems protect themselves from aberrant proteins by a network of chaperones. We have tested in vitro the effects of different concentrations, ranging from 0 to 16 μm, of two molecular chaperones, namely αB-crystallin and clusterin, and an engineered monomeric variant of transthyretin (M-TTR), on the morphology and cytotoxicity of preformed toxic oligomers of HypF-N, which represent a useful model of misfolded protein aggregates. Using atomic force microscopy imaging and static light scattering analysis, all were found to bind HypF-N oligomers and increase the size of the aggregates, to an extent that correlates with chaperone concentration. SDS-PAGE profiles have shown that the large aggregates were predominantly composed of the HypF-N protein. ANS fluorescence measurements show that the chaperone-induced clustering of HypF-N oligomers does not change the overall solvent exposure of hydrophobic residues on the surface of the oligomers. αB-crystallin, clusterin and M-TTR can diminish the cytotoxic effects of the HypF-N oligomers at all chaperone concentration, as demonstrated by MTT reduction and Ca2+ influx measurements. The observation that the protective effect is primarily at all concentrations of chaperones, both when the increase in HypF-N aggregate size is minimal and large, emphasizes the efficiency and versatility of these protein molecules.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26812789     DOI: 10.1515/hsz-2015-0250

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  13 in total

1.  Inhibition of amyloid beta fibril formation by monomeric human transthyretin.

Authors:  Kanchan Garai; Ammon E Posey; Xinyi Li; Joel N Buxbaum; Rohit V Pappu
Journal:  Protein Sci       Date:  2018-03-14       Impact factor: 6.725

2.  FRET studies of various conformational states adopted by transthyretin.

Authors:  Seyyed Abolghasem Ghadami; Francesco Bemporad; Benedetta Maria Sala; Guido Tiana; Stefano Ricagno; Fabrizio Chiti
Journal:  Cell Mol Life Sci       Date:  2017-05-06       Impact factor: 9.261

3.  Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.

Authors:  Roberta Cascella; Claudia Capitini; Giulia Fani; Christopher M Dobson; Cristina Cecchi; Fabrizio Chiti
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

Review 4.  Transthyretin and BRICHOS: The Paradox of Amyloidogenic Proteins with Anti-Amyloidogenic Activity for Aβ in the Central Nervous System.

Authors:  Joel N Buxbaum; Jan Johansson
Journal:  Front Neurosci       Date:  2017-03-15       Impact factor: 4.677

Review 5.  Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity.

Authors:  Benedetta Mannini; Fabrizio Chiti
Journal:  Front Mol Neurosci       Date:  2017-04-05       Impact factor: 5.639

6.  Rationally Designed Antibodies as Research Tools to Study the Structure-Toxicity Relationship of Amyloid-β Oligomers.

Authors:  Ryan Limbocker; Benedetta Mannini; Rodrigo Cataldi; Shianne Chhangur; Aidan K Wright; Ryan P Kreiser; J Alex Albright; Sean Chia; Johnny Habchi; Pietro Sormanni; Janet R Kumita; Francesco S Ruggeri; Christopher M Dobson; Fabrizio Chiti; Francesco A Aprile; Michele Vendruscolo
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

7.  Squalamine and Its Derivatives Modulate the Aggregation of Amyloid-β and α-Synuclein and Suppress the Toxicity of Their Oligomers.

Authors:  Ryan Limbocker; Roxine Staats; Sean Chia; Francesco S Ruggeri; Benedetta Mannini; Catherine K Xu; Michele Perni; Roberta Cascella; Alessandra Bigi; Liam R Sasser; Natalie R Block; Aidan K Wright; Ryan P Kreiser; Edward T Custy; Georg Meisl; Silvia Errico; Johnny Habchi; Patrick Flagmeier; Tadas Kartanas; Jared E Hollows; Lam T Nguyen; Kathleen LeForte; Denise Barbut; Janet R Kumita; Cristina Cecchi; Michael Zasloff; Tuomas P J Knowles; Christopher M Dobson; Fabrizio Chiti; Michele Vendruscolo
Journal:  Front Neurosci       Date:  2021-06-18       Impact factor: 4.677

8.  Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism.

Authors:  Ryan Limbocker; Benedetta Mannini; Francesco S Ruggeri; Roberta Cascella; Catherine K Xu; Michele Perni; Sean Chia; Serene W Chen; Johnny Habchi; Alessandra Bigi; Ryan P Kreiser; Aidan K Wright; J Alex Albright; Tadas Kartanas; Janet R Kumita; Nunilo Cremades; Michael Zasloff; Cristina Cecchi; Tuomas P J Knowles; Fabrizio Chiti; Michele Vendruscolo; Christopher M Dobson
Journal:  Commun Biol       Date:  2020-08-13

9.  Trodusquemine enhances Aβ42 aggregation but suppresses its toxicity by displacing oligomers from cell membranes.

Authors:  Ryan Limbocker; Sean Chia; Francesco S Ruggeri; Michele Perni; Roberta Cascella; Gabriella T Heller; Georg Meisl; Benedetta Mannini; Johnny Habchi; Thomas C T Michaels; Pavan K Challa; Minkoo Ahn; Samuel T Casford; Nilumi Fernando; Catherine K Xu; Nina D Kloss; Samuel I A Cohen; Janet R Kumita; Cristina Cecchi; Michael Zasloff; Sara Linse; Tuomas P J Knowles; Fabrizio Chiti; Michele Vendruscolo; Christopher M Dobson
Journal:  Nat Commun       Date:  2019-01-15       Impact factor: 14.919

10.  Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.

Authors:  Laura Boi; Augusta Pisanu; Maria Francesca Palmas; Giuliana Fusco; Ezio Carboni; Maria Antonietta Casu; Valentina Satta; Maria Scherma; Elzbieta Janda; Ignazia Mocci; Giovanna Mulas; Anna Ena; Saturnino Spiga; Paola Fadda; Alfonso De Simone; Anna R Carta
Journal:  Int J Mol Sci       Date:  2020-11-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.